Pharma & Biotech

As the patent protection for its blockbuster drug Jakafi approaches expiration, biopharmaceutical firm Incyte is implementing a two-pronged strategy to...

Shares of Viking Therapeutics experienced a notable upswing this week, climbing 7.4% on Wednesday to close at $26.82. The catalyst...

In a trading session characterized by broad market weakness, Mirati Therapeutics shares demonstrated exceptional resilience. The stock held completely flat,...

As markets experienced volatility in September, heavyweight investors demonstrated significant conviction in Vertex Pharmaceuticals. Both institutional players and corporate insiders...

Idorsia Ltd. shares are under significant selling pressure in the current trading session, continuing a pattern of high volatility. The...

Redcare Pharmacy shares are trading near their 52-week low, having shed more than 40% of their value since the start...

Clinical-stage biotech firm Sensei Biotherapeutics has scheduled a pivotal virtual event for October 20, 2025, where key opinion leaders will...

Arrowhead Pharmaceuticals is demonstrating how a biotech firm can capture significant market attention through pioneering science and substantial corporate alliances....

The telehealth company Hims & Hers finds itself navigating a significant regulatory challenge following action by the U.S. Food and...

Shares of Viking Therapeutics are experiencing significant turbulence as conflicting forces within the biotechnology sector create a challenging landscape for...